cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2000; 35:188-193
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leonelli, F. M.
Right arrow Articles by Knapp, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonelli, F. M.
Right arrow Articles by Knapp, C. F.

CLINICAL STUDIES

False positive head-up tilt:

Hemodynamic and neurohumoral profile

Fabio M. Leonelli, MD, FACC* {ddagger}, Ke Wang, MD* {ddagger}, Joyce M. Evans, MS{dagger} {ddagger}, Abhijit R. Patwardhan, PhD{dagger} {ddagger}, Michael G. Ziegler, MD{ddagger} §, Andrea Natale, MD* {ddagger}, Charles S. Kim, BSE{dagger} {ddagger}, Kathleen Rajikovich, RN* {ddagger} and Charles F. Knapp, PhD{dagger} {ddagger}

* Department of Cardiology, University of Kentucky, Lexington, Kentucky, USA
{dagger} Center for Biomedical Engineering, University of Kentucky, Lexington, Kentucky, USA
{ddagger} Department of Medicine, University of Kentucky, Lexington, Kentucky, USA
§ University of San Diego, San Diego, California, USA

Manuscript received July 24, 1998; revised manuscript received July 8, 1999, accepted September 10, 1999.

Reprint requests and correspondence: Dr. Fabio Leonelli, 740 South Limestone Street, Room L543, KY Clinic, University of Kentucky, Lexington, Kentucky 40536-0084


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary
 References
 
OBJECTIVES

This study examined differences in mechanisms of head-up tilt (HUT)-induced syncope between normal controls and patients with neurocardiogenic syncope.

BACKGROUND

A variable proportion of normal individuals experience syncope during HUT. Differences in the mechanisms of HUT-mediated syncope between this group and patients with neurocardiogenic syncope have not been elucidated.

METHODS

A 30-min 80° HUT was performed in eight HUT-negative volunteers (Group I), eight HUT-positive volunteers (Group II) and 15 patients with neurocardiogenic syncope. Heart rate and blood pressure (BP) were monitored continuously. Epinephrine and norepinephrine plasma levels, as well as left ventricular dimensions and contractility determined by echocardiography, were measured at baseline and at regular intervals during the test.

RESULTS

The main findings of this study were the following: 1) All parameters were similar at baseline in the three groups; and 2) During tilt: a) the time to syncope was shorter in Group III than in group II (9.5 ± 3 vs. 17 ± 3 min p < 0.05); b) there was an immediate, persisting drop in mean BP in Group III; c) the decrease rate of left ventricular end-diastolic dimensions was greater in Group III than in Group II or Group I (–1.76 ± 0.42 vs. –0.87 ± 0.35 and –0.67 ± 0.29 mm/min, respectively, p < 0.05); d) the left ventricular shortening fraction was greater in Group III than in the other two groups (39 ± 1 vs. 34 ± 1 and 32 ± 1%, respectively, p < 0.05); and e) although the norepinephrine level remained comparable among the groups, there was a significantly higher peak epinephrine level in Group III than in Group II and Group I (112.3 ± 34 vs. 77.6 ± 10 and 65 ± 12 pg/ml, p < 0.05).

CONCLUSIONS

Mechanisms of syncope during HUT appeared to be different in normal volunteers and patients with neurocardiogenic syncope. In the latter, there was evidence of an impaired vascular resistance response from the beginning of the orthostatic challenge. Furthermore, in the patients there was more rapid peripheral blood pooling, as indicated by the echocardiographic measurements of left ventricular end-diastolic changes, leading to more precocious symptoms. In syncopal patients, the higher level of plasma epinephrine probably mediated the increased cardiac contractility and possibly contributed to the impaired vasoconstrictive response.

Abbreviations and Acronyms
  BP = blood pressure
  ECG = electrocardiogram
  HR = heart rate
  HUT = head-up tilt
  LVEDD = left ventricular end-diastolic dimension
  LVESD = left ventricular end-systolic dimension
  SF = shortening fraction


Head-up tilt (HUT) is an accepted diagnostic test in the evaluation of unexplained syncope (1). Its use has become widespread, especially in the management of neurocardiogenic syncope, despite the lack of an accepted diagnostic "gold standard" for this condition, rendering the sensitivity of this test uncertain (2–6). Furthermore, a variable number of normal individuals without any prior history of syncope will have a positive HUT table test (3,7–9). The percentage of false positive studies seems to be related to the age of the subjects (10), duration and angle of tilt (11,12), and use of provocative agents (13). In fact, fainting may be considered one of the expected responses to this test as normal individuals left standing and dependent for a prolonged period of time will develop hypotension, cerebral hypoperfusion and finally syncope (14). The time course of these events can be accelerated by exercise (15), elevated body temperature (16,17), and prolonged bed rest (18). Because fainting does not occur in these individuals during normal circumstances, it is likely that a positive HUT in normal controls is due to the attendant gravitational stress overcoming some of the essential adjustments to orthostasis.

In contrast, patients with neurocardiogenic syncope, who are symptomatic during normal daily activities, exhibit more profound abnormalities in the adaptive responses to orthostasis. These abnormalities can be easily uncovered by HUT testing. Comparing hemodynamic and humoral responses during positive HUT between normal volunteers and patients with neurocardiogenic syncope could define more clearly the abnormalities in the reflex regulation of blood pressure. Should quantification of this response be possible with noninvasive methods, the specificity and sensitivity of the HUT could also be improved, rendering it a more accurate and useful clinical tool in the diagnosis of this elusive condition. With this purpose in mind, we compared hemodynamic and humoral responses during HUT-mediated syncope in a group of patients with neurocardiogenic syncope and a group of normal volunteers.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary
 References
 
Normal subjects (groups I and II).   Sixteen volunteers recruited from the staff or students of the University of Kentucky, gender- and age-matched to the patients (Group III), were included in this group. They had no previous history of syncope or presyncope and showed normal cardiovascular function by clinical exam, 12-lead electrocardiogram (ECG), and standard echocardiographic evaluation. This group was further subdivided, according to the response to HUT; Group I with negative HUT response (8 subjects, 4 men and 4 women, mean age 34 ± 2 years) and Group II, experiencing syncope during HUT (8 subjects, 4 men and 4 women, mean age 31 ± 2 years).

Patients with unexplained syncope (group III).   Patients with unexplained syncope were included in the study if they met the following criteria:

  1. At least two syncopal episodes in the last six months that remained unexplained despite a careful history, comprehensive physical examination, full neurological evaluation, 12-lead ECG, 24-h ambulatory Holter monitoring, and echocardiography.
  2. No history of hypertension or usage of drugs known to cause orthostatic hypotension.
  3. Technically optimal echocardiographic images.
  4. Normal heart structure and function by echocardiographic criteria.
  5. Positive HUT that reproduced the clinical symptoms with evidence of hypotension (systolic blood pressure [BP] less than 90 mm Hg) and/or bradycardia (heart rate [HR] less than 60 beats/min).

Fifteen consecutive patients, six men and nine women, mean age 30 ± 4 years, referred to the University of Kentucky between June 1996 and August 1997, met these criteria and were included in the present study.

HUT protocol.   After obtaining written permission from all participants in the study, the test was performed in a quiet, temperature-controlled room in the morning following an overnight fast. The protocol included 20 min of baseline rest in the supine state followed by 30 min of HUT at 80° with a foot board for weight bearing and three waistbands around the body to fold the subject in case of syncope. The test was terminated prematurely if the subject experienced hypotension (systolic BP less than 90 mm Hg) and/or bradycardia (HR less than 60 beats/min). Blood pressure and ECG leads II, III, and aVF were continuously monitored using SpaceLabs ECG recording and Finapres TM BP Monitor (Ohmeda 2300). Blood pressure values recorded with the finger sphygmomanometer were compared every 4 min with values obtained from a standard cuff sphygmomanometer to confirm their accuracy. If more than a 10% difference between these two values was detected during the resting phase, the position of the finger sphygmomanometer was changed. If such a discrepancy was found during tilt, the Finapres was allowed to undergo one or more cycles of automatic recalibration. In the situation where this maneuver did not normalize the readings, the entire data set was discarded.

Electrocardiographic and BP data were continuously displayed on a monitor, recorded on a strip chart recorder (Astromed 9000, Astromed, West Warwick, Rhode Island), digitized on line at the rate of 250 samples per second using a commercial system (DATA Q) and stored for subsequent analysis. To correlate BP and HR with left ventricular dimensions, a 30-s segment of these parameters, recorded at the time of echocardiography, was later retrieved and analyzed.

Echocardiographic analysis.   Two-dimensional echocardiography was performed using a Hewlett-Packard 77020 A sonos 1000 ultrasonograph and a 2.5-MHz phased-array transducer. A standard parasternal short-axis view at the level of the papillary muscles was recorded during the supine resting stage, 2 min after initiation of HUT and every 4 min thereafter until the end of the test or at the onset of symptoms. Left ventricular end-diastolic dimension (LVEDD) and left ventricular end-systolic dimension (LVESD) were determined using M-mode echocardiography. Percent of left ventricular fractional shortening (SF) was calculated: [(end diastolic dimension – end systolic dimensions)/end diastolic dimensions) x 100].

All echocardiographic data were analyzed from stopped-frame videotape and strip-chart recordings by the same investigator so as to minimize interobserver variations. Each value was obtained by averaging at least five consecutive heart beats.

Hormonal assay.   An antecubital-indwelling catheter was placed 1 h prior to the beginning of the study. Ten milliliters of blood was drawn at the end of the supine rest and at 8-min intervals during HUT. In subjects with positive HUT, a sample was drawn at the appearance of syncopal symptoms. All samples were immediately spun, plasma was extracted and frozen, and samples subsequently delivered to the laboratory where radioenzymatic assays for plasma norepinephrine and epinephrine were performed (19).

Statistical analysis.   Group data are expressed as mean value ± SE. Two-factor analysis of variance (time and group) with multiple comparisons on the time factor was used to determine responses to tilt for the three groups of subjects. When significant effects were found, appropriate t tests were made using Bonferroni correction. A p value of 0.05 was considered to be statistically significant. A second investigator, blinded to the stage of the study, reviewed all the echocardiographic measurements of left ventricular end-diastolic and -systolic volume to allow an estimation of the interobserver variability. For interobserver variability, the correlation coefficients were 0.92 (p < 0.001) and 0.94 (p < 0.001), respectively. Changes in left ventricular dimension and SF over time were assessed for each group. Regression was used to compare the rate of change of these parameters among these three groups. The estimated beta coefficient obtained from regression slopes in the three groups was compared using the statistical analysis previously described.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary
 References
 
Cardiovascular responses.   Baseline mean BPs and HRs were comparable in the three groups. During HUT, the mean BP in Group I did not change from baseline, while the mean HR increased from 62 ± 5 to 95 ± 10 beats/min (p < 0.05). All subjects in this group completed 30 min of HUT. The duration of HUT was different in Groups II and III as symptoms of presyncope appeared at 17 ± 3 min in the former and 9.5 ± 3 min in the latter (p < 0.05) (see Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1 Average Values of Mean Blood Pressure and Heart Rate ± SE During 80° HUT

 
There was an equal distribution of vasodepressor and mixed hemodynamic responses (14,15) to HUT in both groups. In Group II there were four patients with vasodepressor and four with mixed response, whereas in Group III, symptoms were associated with a vasodepressor response in nine and a mixed response in six patients. The BP response in volunteers with a positive HUT response (Group II) remained unchanged from baseline until the development of presyncope, while there was a progressive increase in mean HR throughout the test. This change was similar to that observed in Group I.

In the group of patients with neurocardiogenic syncope, the HR response was comparable to the response in the other two groups. However, this group demonstrated an appreciable decrease in mean BP from the supine value within the first 2 min of tilt. This value decreased from 92 ± 3 mm Hg to 83 ± 4 mm Hg at 2 min (p < 0.05) and continued to decrease to 79 ± 4 mm Hg at 2 min before symptoms became manifest. These values were different both from baseline and from the values recorded at the same stage in Group I.

Left ventricular dimensions.   Left ventricular end-diastolic dimension and LVESD, as well as shortening fraction (SF) values, were similar in the three groups at baseline (Fig. 1). Changes in these parameters were not significant in Group I throughout the entire upright tilt part of the protocol. In Group II, SF remains unchanged, while LVESD and LVEDD measurements decreased during the test, becoming significantly less than control 2 min before the end of the test, although they remained comparable to the values from Group I. In Group III (patients with neurocardiogenic syncope), all three parameters of left ventricular function were different from baseline at 2 min into the test, and LVESD and LVEDD measurements became different from Group I 2 min before the end of HUT. Moreover, SF significantly increased throughout the test to become, at 2 min before the end of HUT, statistically different from the other two groups (39 ± 1% in Group III, 34 ± 1 and 32 ± 1% in Groups II and I, respectively; p < 0.05). The rate of decrease in LVESD and LVEDD was greater in Group III than in Group II or Group I (–1.76 ± 0.42 vs. –0.87 ± 0.35 vs. –0.17 ± 0.03 mm/min for the former and –1.68 ± 0.4 vs. –0.67 ± 0.29 vs. –0.11 ± 0.03 mm/min for the latter, p < 0.05).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 1 Changes in left ventricular end-systolic dimensions (LVESD), left ventricular end-diastolic dimensions (LVEDD), shortening fraction (SF), and rate of change of the same parameters during HUT in the three groups. Throughout the test, end-diastolic, end-systolic dimension, and SF did not change significantly in Group I. In Group II the LVEDD and the SF changed significantly from the baseline values but remained similar to Group I. In Group III all of these parameters changed from baseline; furthermore, the LVEDDs were different from Group I, and the SF was different from both groups. Although LVEDDs were comparable in Group II and Group III, the rate of change in Group III was different from the other two. *p < 0.05 versus Group I. {dagger}p < 0.05 from baseline. {ddagger}p < 0.05 versus baseline, Group I and II. mm = millimeters; min = minutes; HUT = head-up tilt; before = 1 or 2 min before the end of HUT.

 
Catecholamine changes.   Epinephrine and norepinephrine values were similar in the three groups at baseline (Fig. 2). Norepinephrine levels increased during HUT in a comparable manner in all three groups. Epinephrine levels increased during the test in every subject. Patients with neurocardiogenic syncope had a sixfold increase from the baseline value (18 ± 3 to 112 ± 34 pg/ml, p < 0.05) at the onset of bradycardia and hypotension. This value was statistically different from the other two groups.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 2 Changes in epinephrine and norepinephrine plasma levels during head-up tilt. The three groups exhibited similar increases in norepinephrine levels during the test. The increase in epinephrine level during HUT was higher in Group III than in the other groups. {ddagger}p < 0.05 versus baseline, Group I and II. HUT = head-up tilt.

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary
 References
 
Earlier studies.   Cardiovascular adjustments to gravitational stress have been an object of study for well over a century. The HUT has long (20) been considered a convenient model to study reflex responses to gravitational stress. Both hypotension and bradycardia leading to syncope during HUT are not infrequent events in normal subjects (3,7–9). These responses were considered to be part of a reflex response triggered by a sympathetic-induced hypercontraction of an almost empty left ventricular chamber (21). More recently (1), HUT has became an accepted diagnostic tool in the study of a poorly understood clinical entity often referred to as "neurocardiogenic syncope." However, the frequency of false positive responses was immediately appreciated as a problem inherent in this test (6,13), leading some investigators to suggest that HUT should be used as a confirmatory test to support a clinically based diagnosis (13). Although HUT-mediated syncope can occur in normal subjects, hemodynamic and humoral responses leading to this event may be qualitatively different from the responses of HUT-positive individuals who experience syncope during normal daily activities. Comparison of the pattern of responses in these two groups could lead to a better definition of the abnormal regulatory mechanisms leading to pathological syncope and consequently improve the specificity of HUT.

Differences between groups.   Our study shows that a number of differences and similarities exist between these two groups. First, the time to syncope was about twice as long in the controls as in the patients. During the test, the HR and BP responses of the HUT-positive groups differed. The patients (Group III) exhibited a drop in BP as early as 2 min into the test accompanied, at the same time, by tachycardia. In syncopal volunteers (Group II), these changes were not present until 2 min before the onset of symptoms and were absent in the normal controls (Group I). The pattern of peripheral blood pooling in the three groups was indirectly estimated by analyzing changes in LVEDD. During the orthostatic challenge, both HUT-positive groups exhibited a progressive decrease in LVEDD, statistically different from baseline value, while the HUT-negative subjects exhibited an initial reduction that quickly stabilized, an effect that has been previously reported (22). Although the dimensions themselves are not different between the two HUT-positive groups, the different rates of dimension reduction are suggestive of a more rapid peripheral fluid shift in patients with neurocardiogenic syncope.

Decreased venous return: possible etiology.   The BP response and the rapid reduction in venous return during orthostatic challenge are suggestive of an abnormality in vascular control.

This hypothesis is in agreement with previous work suggesting an impaired vasoconstrictor response in patients with neurocardiogenic syncope during tilt test (23) and during dynamic leg exercise (24,25). The mechanisms of this apparent failure of reflex vasoconstriction are unclear. Multiple reflexes are involved in the maintenance of BP during orthostatic stress (26). Although failure of any of these responses has never been conclusively demonstrated, intrinsic abnormality of cardiopulmonary mechanoreceptor function has been postulated to exist in these individuals (27). By contrast, epinephrine might contribute to inappropriate vasodilation. Epinephrine peaked in patients with neurocardiogenic syncope just before the occurrence of symptoms. From our data it is unclear whether the significant increase in epinephrine in Group III at the onset of symptoms represents a cause for the syncope or merely the failing attempt of the sympathetic system to maintain the cardiac output. This hormone dilates skeletal muscle and splanchnic resistance vessels at concentrations measured in humans under stress (28,29). The HUT-positive volunteers had normal SF and normal epinephrine levels, suggesting that this hormone plays only a marginal role in their syncopes. The reflex inducing syncope seems to differ between patients and normal volunteers. The patients had left ventricular hypercontractility, possibly secondary to high plasma levels of epinephrine. The left ventricular SF of the HUT-positive volunteers was comparable to the nonfainting controls. This finding casts doubt on the importance of the Bezold-Jarish reflex (30) triggering bradycardia and hypotension during tilt, at least, in the normal controls.


    Summary
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary
 References
 
In summary, we have shown that the hemodynamic and humoral responses to HUT were different in syncopal patients and in controls. In patients, this test unmasked postural hypotension that could have been worsened by excessive circulating epinephrine. In HUT-positive normal volunteers, the progression to syncope was slower and accompanied by epinephrine responses similar to nonsyncopal volunteers. Noninvasive quantification of BP, rate of change of left ventricular end-diastolic volume, SF of this chamber, and epinephrine plasma levels discriminated syncopal responses of patients with neurocardiogenic syncope from that of positive normal volunteers. It may be possible to define an algorithm combining these parameters that defines an abnormal response to this orthostatic challenge.

Study limitations.   In our study, we evaluated changes in BP and left ventricular dimensions during HUT using finger plethysmography and echocardiography. Invasive hemodynamic monitoring is more accurate but sometimes induces syncope (30–32). The rate of false positive response to HUT was higher in our subjects than any previously published rate in controls (1). Nevertheless, our data are strongly supported by a recent report (33) showing, in a large group of normal volunteers, a linear correlation between the incidence of syncope and the duration of a 50° HUT. As in our group, at 30 min into the test, 50% of their subjects (33) had experienced hypotension and bradycardia, forcing termination of the tilt. This suggests that the specificity of this test is duration dependent and may be lower than previously reported.

Our conclusions were based on a relatively small preselected sample of subjects, which prevents us from generalizing our observations to the population at large. Therefore, the proposed monitoring of selected parameters to increase the specificity and sensitivity of HUT in the diagnosis of neurocardiogenic syncope awaits trials with larger numbers of patients. Although our observation of different rates of venous return in the three groups suggests an abnormality in vasoconstrictive response, we have performed no direct measurements to support our contention. Demonstration of this speculation should be the focus of future research. We hypothesized that the higher level of epinephrine could explain the different hemodynamic profile of the patients. Others have suggested (34) that patients with this condition have a beta-receptor hypersensitivity, which could exacerbate responses to epinephrine. Finally, we cannot exclude that other reflexes (35) or circulating hormones (36,37) play a contributory role in patients’ abnormal response to HUT.


    Footnotes
 
Supported in part by NASA grant EPSCoR WKU 522611, NIH grant MO1RR02602, and an Industrial Grant from St. Jude Medical Co.


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary
 References
 

  1. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol. 1996;28:263–275[CrossRef][Medline]
  2. Fitzpatrick A, Theokorakis G, Vardas P, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991;12:389–394[Abstract/Free Full Text]
  3. Kenny RA, Bayliss J, Ingram A, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1:1352–1354[CrossRef][Medline]
  4. Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med. 1991;114:1013–1019[Medline]
  5. Raviele A, Gasparini G, DiPede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol. 1990;65:1322–1327[CrossRef][Medline]
  6. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: comprehensive literature review. Am J Med. 1994;97:78–88[CrossRef][Medline]
  7. Smith JJ. Circulatory response to the upright posture. Boca Raton, FL: CRC Press; 1990. p. 30–33
  8. Graybiel A, McFarland RA. The use of the tilt table in aviation medicine. Aviat Med. 1941;11:194–211
  9. Wagner HN. Orthostatic hypotension. Bull Johns Hopkins Hosp. 1959;105:322–359
  10. De Jong-de Vos van Steenwijk CCE, Wieling W, Johannes J, Harms MP, Kuis W, Wessling KH. Incidence and hemodynamic characteristics of near-fainting in healthy 6- to 16-year old subjects. J Am Coll Cardiol. 1995;25:1615–1621[Abstract]
  11. Natale A, Aktar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or pre-syncope. Circulation. 1995;92:54–58[Abstract/Free Full Text]
  12. Lewis DA, Zlotocha J, Henke L, Dhala A. Specificity of head-up tilt testing in adolescents: effect of various degrees of tilt challenge in normal control subjects. J Am Coll Cardiol. 1997;30:1057–1060[Abstract]
  13. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. Ann Intern Med. 1992;116:358–363[Medline]
  14. Sander-Jensen K, Secher NH, Astrup A, et al. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol. 1986;251:R742–R748
  15. Bjurstedt H, Rosenhamer G, Balldin U, Katkov V. Orthostatic reactions during recovery from exhaustive exercise of short duration. Acta Physiol Scand. 1983;119:25–31[Medline]
  16. Rowell LB, Brengelmann GL, Blackmon JR, Murray JA. Redistribution of blood flow during sustained high skin temperature in resting man. J Appl Physiol. 1970;28:415–420[Free Full Text]
  17. Lind AR, Leithead CS, McNicol GW. Cardiovascular changes during syncope induced by tilting men in the heat. J Appl Physiol. 1968;25:268–276[Free Full Text]
  18. Blomqvist CG, Stone HL. Cardiovascular adjustments to gravitational stress. Shepherd JT, Abboud FM, Geiger SR. Handbook of Physiology. The Cardiovascular System: Peripheral Circulation and Organ Blood Flow, Sec. 2, Vol. III, Pt. 2. Bethesda, MD: American Physiological Society; 1983. p. 1025–1063
  19. Kennedy B, Fisher MG. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci. 1990;47:2143–2153[CrossRef][Medline]
  20. Allen SC, Taylor CL, Hall VE. A study of orthostatic insufficiency by the tiltboard method. Clin Sci Lond. 1950;9:79–90
  21. Oberg B, Thorne P. Increased activity in the left ventricular receptors during hemorrhage or occlusion of caval veins in the cat: a possible cause of the vasovagal reaction. Acta Physiol Scand. 1972;85:164–173[Medline]
  22. Shalev Y, Gal R, Tchou PJ, et al. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. J Am Coll Cardiol. 1991;18:746–751[Abstract]
  23. Sneddon JF, Counihan PJ, Bashir Y, Haywood GA, Ward DE, Camm AJ. Impaired immediate vasoconstrictor responses in patients with recurrent neurally mediated syncope. Am J Cardiol. 1993;71:72–76[CrossRef][Medline]
  24. Thomson HL, Lele SS, Atherton JJ, Wright KN, Stafford W, Frenneaux MP. Abnormal forearm vascular responses during dynamic leg exercise in patients with vasovagal syncope. Circulation. 1995;92:2204–2209[Abstract/Free Full Text]
  25. Thomson HL, Atherton JJ, Khafagi FA, Frenneaux MP. Failure of reflex venoconstriction during exercise in patients with vasovagal syncope. Circulation. 1996;93:953–959[Abstract/Free Full Text]
  26. Abboud FM, Heistad DD, Mark AL, Schmid PG. Reflect control of the peripheral circulation. Prog Cardiovasc Dis. 1976;17:371–403
  27. Sneddon JF, Counihan PJ, Bashir Y, Haywood GA, Ward DE, Camm AJ. Assessment of autonomic function in patients with neurally mediated syncope: augmented cardiopulmonary baroreceptor responses to graded orthostatic stress. J Am Coll Cardiol. 1993;21:1193–1198[Abstract]
  28. Rowell LB, Seals DR. Sympathetic activity during graded central hypovolemia and hypoxemic humans. Am J Physiol. 1990;:H1197–H1206
  29. Rowell LB, Blackmon JR. Hypotension induced by central hypovolaemia and hypoxaemia. Clin Physiol. 1989;9:269–277[Medline]
  30. Linden RJ. Reflexes from the heart. Prog Cardiovasc Dis. 1975;18:201–221[CrossRef][Medline]
  31. McIntosh SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing. 1994;23:317–319[Abstract/Free Full Text]
  32. Imholz BPM, Wielding W, Langewouters GJ, Van Monfrants GA. Continuous finger arterial pressure utility in the cardiovascular laboratory. Clin Auton Res. 1991;1:45–53
  33. Madsen P, Svendsen L, Jorgensen L, Matzen S, Jansen E, Secher N. Tolerance to head-up tilt and suspension with elevated legs. Aviat Space Environ Med. 1998;69:781–784[Medline]
  34. Perry JC, Garson A. The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity. J Am Coll Cardiol. 1991;17:1168–1171[Abstract]
  35. Dickinson CJ. Fainting precipitated by collapse-firing of venous baroreceptors. Lancet. 1993;342:970–972[CrossRef][Medline]
  36. Kaufmann H, Oribe E, Oliver JA. Plasma endothelin during upright tilt: relevance for orthostatic hypotension? Lancet. 1991;338:1542–1545[CrossRef][Medline]
  37. Shen WK, Hammill SC, Munger TM, et al. Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol. 1996;28:146–154[Abstract]




This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leonelli, F. M.
Right arrow Articles by Knapp, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonelli, F. M.
Right arrow Articles by Knapp, C. F.

 
  cardiology careers collections past issues search home